These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 5078897)

  • 1. Pseudoparkinsonism and tardive dyskinesia.
    Crane GE
    Arch Neurol; 1972 Nov; 27(5):426-30. PubMed ID: 5078897
    [No Abstract]   [Full Text] [Related]  

  • 2. The membrane actions of tranquilizers in relation to neuroleptic-induced parkinsonism and tardive dyskinesia.
    Seeman P; Staiman A; Lee T; Chau-Wong M
    Adv Biochem Psychopharmacol; 1974; 9(0):137-48. PubMed ID: 4151919
    [No Abstract]   [Full Text] [Related]  

  • 3. Tardive dyskinesia: its relation to neuroleptic and antiparkinson drugs.
    Turek I; Kurland AA; Hanlon TE; Bohm M
    Br J Psychiatry; 1972 Dec; 121(565):605-12. PubMed ID: 4648433
    [No Abstract]   [Full Text] [Related]  

  • 4. Tardive dyskinesia: an evaluation of the etiologic association with neuroleptic therapy.
    Baldessarini RJ
    Can Psychiatr Assoc J; 1974 Dec; 19(6):551-4. PubMed ID: 4613452
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of cholinergic and anticholinergic agents on tardive dyskinesia.
    Klawans HL; Rubovits R
    J Neurol Neurosurg Psychiatry; 1974 Aug; 37(8):941-7. PubMed ID: 4418481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurological syndromes associated with antipsychotic drug use. A special report.
    Freedman DX
    Arch Gen Psychiatry; 1973 Apr; 28(4):463-7. PubMed ID: 4692143
    [No Abstract]   [Full Text] [Related]  

  • 7. Tardive dyskinesia in schizophrenic patients treated with psychotropic drugs.
    Crane GE
    Agressologie; 1968; 9(2):209-18. PubMed ID: 5675488
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical evaluation of a new neuroleptic "thiothixene" (p-4657 b).
    Gómez-Martínez I
    Psychiatr Neurol (Basel); 1967; 153(4):219-25. PubMed ID: 5340209
    [No Abstract]   [Full Text] [Related]  

  • 9. Polygraphic studies of tardive dyskinesia and of the rabbit symdrome during different stages of sleep.
    Villeneuve A; Jus K; Jus A
    Biol Psychiatry; 1973 Jun; 6(3):259-74. PubMed ID: 4732255
    [No Abstract]   [Full Text] [Related]  

  • 10. [Individual predisposition for unusual extrapyramidal side effects with neuroleptic agents].
    Lingjaerde O
    Tidsskr Nor Laegeforen; 1971 May; 91(13):977-9. PubMed ID: 5576970
    [No Abstract]   [Full Text] [Related]  

  • 11. Neurologic syndromes associated with antipsychotic-drug use.
    N Engl J Med; 1973 Jul; 289(1):20-3. PubMed ID: 4708951
    [No Abstract]   [Full Text] [Related]  

  • 12. Is tardive dyskinesia a drug effect?
    Crane GE
    Am J Psychiatry; 1973 Sep; 130(9):1043-4. PubMed ID: 4727768
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug-induced Parkinson-like syndrome.
    Va Med Mon (1918); 1968 Dec; 95(12):746-50 passim. PubMed ID: 5725399
    [No Abstract]   [Full Text] [Related]  

  • 14. Letter: Tardive dyskinesia.
    Thornton WE
    JAMA; 1973 Nov; 226(6):674. PubMed ID: 4800621
    [No Abstract]   [Full Text] [Related]  

  • 15. [Somatic disorders during long-term drug treatment of schizophrenic patients].
    vom Brocke I
    Internist (Berl); 1974 May; 15(5):268-70. PubMed ID: 4213663
    [No Abstract]   [Full Text] [Related]  

  • 16. Epidemiology of tardive dyskinesia. Part II.
    Jus A; Pineau R; Lachance R; Pelchat G; Jus K; Pires P; Villeneuve R
    Dis Nerv Syst; 1976 May; 37(5):257-61. PubMed ID: 1261344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dyskinesia and neuroleptics.
    Crane GE
    Arch Gen Psychiatry; 1968 Dec; 19(6):700-3. PubMed ID: 5697636
    [No Abstract]   [Full Text] [Related]  

  • 18. [Neurologic and psychic complications in treatment with neuroleptics].
    Gerlach J
    Ugeskr Laeger; 1976 Jun; 138(27):1650-3. PubMed ID: 951778
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experience with the use of midantan for treatment and prevention of the neuroleptic syndrome].
    Kamianov IM; Kupisk AG; Katsen IZ
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(8):1218-23. PubMed ID: 4149581
    [No Abstract]   [Full Text] [Related]  

  • 20. Neutralization of extrapyramidal side-effects with Methixene.
    Maller O; Heller S
    Dis Nerv Syst; 1971 Jun; 32(6):409-15. PubMed ID: 5570695
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.